Related Experiment Video
Updated: Jul 24, 2025

An Assay for Quantifying Protein-RNA Binding in Bacteria
Published on: June 12, 2019
Phage anti-CBASS protein simultaneously sequesters cyclic trinucleotides and dinucleotides.
Xueli Cao1,2, Yu Xiao3,2, Erin Huiting4,2
1Beijing Advanced Innovation Center for Soft Matter Science and Engineering, State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.
Phage protein Acb2 acts as a broad-spectrum inhibitor of cyclic GMP-AMP synthase (cGAS)-based immunity. It sequesters diverse cyclic nucleotide signals, protecting phages from bacterial cyclic oligonucleotide-based antiphage signaling (CBASS) systems.
Area of Science:
- Molecular Biology
- Immunology
- Virology
Background:
- Cyclic oligonucleotide-based antiphage signaling (CBASS) is a key bacterial defense against phages.
- Phages encode anti-CBASS (Acb) proteins to counteract these systems.
- Acb2 is a recently identified phage anti-CBASS protein known to bind cyclic dinucleotides.
Conclusions:
- Acb2 functions as a potent, broad-spectrum inhibitor of cGAS-based immunity by sequestering diverse cyclic oligonucleotide signals.
- The dual-pocket structure of Acb2 enables simultaneous neutralization of multiple signaling molecules, highlighting an advanced phage counter-defense strategy.
- Acb2 represents a significant target for understanding and potentially manipulating bacterial anti-phage immunity.
Related Concept Videos
DNA Bacteriophages
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Lytic Cycle of Bacteriophages
GPCRs Regulate Adenylyl Cylase Activity
Lysogenic Cycle of Bacteriophages

